By Cytiva

Published in: Cell & Gene

Published on: January 12, 2022

Introduction: Cell therapies are changing the landscape of clinical care, and their temperature-related vulnerability has made continuous cold chain management even more critical in the delivery of treatments to patients.

Cold chain management comprises three key phases: cooling, storage, and thawing. Thawing errors for a potentially lifesaving therapy could compromise treatment efficacy and may have significant impact on patients, costs, and a product developer’s reputation.

Advance Stability Knowledge

Would you like to see a particular publication, guidance, organization, supplier, event, or career opportunity on StabilityHub? Contact us with your suggestion!